MIRA vs ZS · $41.1M cap vs rev $3.35B
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) versus Zscaler Inc (ZS) — a side-by-side from cached financials, not a winner call.
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a drug manufacturers - general company listed on NASDAQ.
Zscaler Inc (ZS) is a software - infrastructure company listed on US. It is led by Jagtar Singh Chaudhry.
MIRA does not have a complete income-statement cache yet.
Latest reported ZS revenue for 2026-07-31 was $3.35B. Net income was -$63.2M. Revenue was up 25.4% from 2025-07-31 to 2026-07-31. ZS currently screens at market cap $49.01B.
MIRA currently screens at market cap $41.1M. ZS currently screens at market cap $49.01B.
Not investment advice. Open the MIRA and ZS stock pages for the full models.
Not investment advice.